Archive - January 2022
Pharmacist vacancies highlight need for funding booster
PM announces plans to lift England’s COVID-19 restrictions
Merck and Eisai share crucial phase 3 trial results for advanced endometrial carcinoma treatment
U.S. FDA Approves Second Indication for Skyrizi (risankizumab-rzaa) to Treat Adults with Active Psoriatic Arthritis
FDA Approves Veklury (remdesivir) for the Treatment of Non-Hospitalized Patients at High Risk for COVID-19 Disease Progression
Myocarditis: COVID-19 Is A Much Bigger Risk To The Heart Than Vaccination
GSK appoint Tony Wood as chief scientific officer
Sanofi and Regeneron’s Dupixent receives second positive phase 3 trial results